Fatal flop: Will the ‘Morbius’ cast return for an unwelcome sequel?

Marvel’s Morbius arrived with a tidy concept and left behind a very public mess. Jared Leto plays Dr. Michael Morbius, a scientist racing against a rare blood disorder who ends up giving himself vampirism instead of a cure. The premise sounded sharp on paper, yet the finished picture landed with critics and audiences as one of the more awkward 2022 releases, and the jokes have not aged out of rotation since.

The cast list looked promising on announcement. Leto headlined, Michael Keaton appeared as Adrian Toomes, Matt Smith played the rival scientist Milo, and Tyrese Gibson turned up as mercenary Simon Stroud. Their involvement gave the project a veneer of weight, but the end result did not hold the line. The film’s standing as a punchline has lingered, which raises the practical question of whether any of these actors would be asked back for another round under the same banner.

More B.S.

Expectations ran high after Spider-Man: No Way Home delivered crossover energy and strong numbers. Morbius opened to roughly thirty-nine million domestically and finished with a worldwide gross near one hundred sixty-seven point five million against a seventy-five million budget. That placed it as the lowest-earning theatrical entry in Sony’s Spider-Man Universe at the time. The gap between hype and receipts made the film an easy target online, and the mockery included a widely shared fake Martin Scorsese quote praising the movie as peak cinema. Tyrese Gibson posted the meme on his Instagram believing it to be real, then praised director Daniel Espinosa for the work. The post drew quick corrections once the April Fool’s timing became clear.

Streaming Performance and Cult Following

After the theatrical run closed, Morbius found a steadier audience on home platforms. The film’s audience score on Rotten Tomatoes settled at seventy-one percent, a noticeable lift from the fifteen percent Tomatometer. Viewers who returned for repeat watches often cited the campier set pieces and Smith’s unhinged turn as reasons to stick around. The shift did not rewrite the critical record, yet it created a modest aftermarket that kept the title circulating without requiring a new theatrical campaign.

Sony’s Spider-Man Universe Conclusion

Any talk of a direct sequel has to account for the larger studio timeline. Kraven the Hunter closed out the original Sony’s Spider-Man Universe slate in 2024. Following that release, Sony moved resources toward MCU Spider-Man installments and separate projects such as the announced Spider-Noir series. The December 2024 decision ended further theatrical entries under the existing SSU structure, which removed the most direct path for another Morbius chapter built on the 2022 cast and continuity.

Can Morbius be saved?

Al Madrigal, who played FBI agent Alberto Rodriguez, has maintained that the film suffered from over-editing rather than a broken premise. Barry Hertz at The Globe and Mail countered that the picture felt “charmless, incoherent, ugly, and so aggressively stupid” that it resisted any guilty-pleasure defense. Joshua Clark at CBR argued that comic-book movies benefit from tonal variety and that Morbius at least stood apart from standard MCU entries. Those points remain on record, yet the studio path forward has shifted. No Morbius sequel sits in active development as of mid-2026. Sony’s December 2024 decision ended further SSU films, and any future Morbius material would fall under separate plans rather than a continuation of the 2022 storyline.

2026 Reboot Announcement Implications

In February 2026 interviews, Sony Pictures chairman Tom Rothman confirmed plans for a fresh Spider-Man universe reboot built around new creative teams. The comments left room for characters such as Morbius to reappear eventually, though Rothman stressed that any return would involve different personnel and would not function as a direct sequel to the 2022 film. The announcement effectively closed the door on a follow-up that reuses the original cast and crew under the prior SSU framework.

Cast Career Trajectories Post-Morbius

Speculation at the time suggested the film could ding several résumés. In practice the impact stayed limited. Leto moved between major studio roles and continued touring with Thirty Seconds to Mars. Keaton returned to prestige and franchise work that leaned on his established range. Smith maintained a steady schedule across film and prestige television. Gibson and Madrigal each booked subsequent television and supporting film parts without long gaps. The projects that followed did not hinge on Morbius goodwill, which suggests the 2022 release functioned more as a one-off speed bump than a lasting setback.

Four years after release, the ledger on Morbius reads as a clear theatrical disappointment that later found a narrower streaming audience. The Sony Spider-Man Universe that once housed it has reached its conclusion, and current studio statements point toward a reboot rather than a continuation. Any future version of the character would arrive under new leadership and with a different cast. For the actors who appeared in the 2022 film, the next steps have already moved on to other rooms.